戻る Agenda
Session 9: Track A: Labeling Changes and the Impact on Medical Devices
Session Chair(s)
Madhavi Bellamkonda, MSc
Director Regulatory Affairs, Advertising & Promotion
Abbott, United States
This session will be an engaging and interactive session that will focus on the impact of labeling changes in the medical device industry. Specifically, the panel will delve into three aspects:
Learning Objective :
Participants should be able to:
- Assess how to incorporate new clinical trial data in promotional material before label updates
- Describe labeling changes that impact Important Safety Information
- Define effective product launch strategies, such as direct-to-patient marketing and social media launch strategies, when using new clinical trial data
- Discuss the who, how, when, and where for a successful product launch with a new label
Speaker(s)
Labeling for Devices Panel
Gerrit Nijveldt, MSc
Opus Regulatory Inc., United States
Global Labeling Consultant
Speaker
Madhavi Bellamkonda, MSc
Abbott, United States
Director Regulatory Affairs, Advertising & Promotion